Form 4 for CRBU Caribou Biosciences, Inc.
Accepted 2022-12-02 00:00:00 ET · period of report 2022-12-02 · accession 0001619856-22-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-02 | 2022-12-02 | CRBU | Kanner Steven | CSO | M - OptEx | $2.69 | +21.4K | 323.5K | +7% | +$57.6K |
| D | 2022-12-02 | 2022-12-02 | CRBU | Kanner Steven | CSO | M - OptEx | $2.69 | -21.4K | 52.2K | -29% | -$57.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-02 | M | A | 21,401 | $2.69 | 323,460 | D | — | — | |
| 2 | Derivative | Option to purchase Common Stock | 2022-12-02 | M | D | 21,401 | $2.69 | 52,200 | D | $2.69 · — to 2029-09-30 | 21,401 Common Stock | (F1) 1/4th of the shares subject to this option vested on October 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. |